SBH Sciences, Inc. was founded in 1997 with the sole purpose of producing mammalian-derived recombinant cytokines. Since then, we have drastically expanded our services to offer cytokine-measuring bioassays, in vitro anti-cancer and anti-inflammatory lead drug development, as well as the development of ELISA kits and our biomarker Multiplex analyses. In the last few years, we have continued our growth through partnerships with several companies; our product line now includes specific enzymes, and in vivo cancer and NASH models. Additionally, we enhanced our biomarker analysis capabilities to include: AlphaScreen/AlphaLISA, Analytical HPLC, ELISA, ELLA, Flow Cytometry, HTRF®, Luminex, Peggy Sue / WES, and Real-Time PCR.What We Do and Our Accomplishments:
SBH Sciences, Inc. is a preclinical Contract Research Organization (CRO) offering extensive products and services including: Analysis of over 150 Biomarkers with expanded Multiplex analysis capabilities, 350 human cancer cell lines on hand, 300 cell-based bioassays, commercial production of 31 recombinant cytokines, 8 recombinant Glycosyltransferase enzymes, 33 monoclonal antibodies, and the development of 30 ELISA kits. SBH Sciences is the world leader in cell-based assays to measure biological activity of cytokines and growth factors, and has provided services to over 180 biotechnology companies across the globe during our 20 years of business.